chr16-88877026-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005187.6(CBFA2T3):c.1912C>T(p.Arg638Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000747 in 1,338,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
CBFA2T3
NM_005187.6 missense
NM_005187.6 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 1.08
Genes affected
CBFA2T3 (HGNC:1537): (CBFA2/RUNX1 partner transcriptional co-repressor 3) This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(16;21)(q24;q22) translocation is one of the less common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. This gene is also a putative breast tumor suppressor. Alternative splicing results in transcript variants. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10819495).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBFA2T3 | NM_005187.6 | c.1912C>T | p.Arg638Cys | missense_variant | 12/12 | ENST00000268679.9 | NP_005178.4 | |
CBFA2T3 | NM_175931.3 | c.1654C>T | p.Arg552Cys | missense_variant | 11/11 | NP_787127.1 | ||
CBFA2T3 | XM_005256323.6 | c.1837C>T | p.Arg613Cys | missense_variant | 11/11 | XP_005256380.1 | ||
CBFA2T3 | XM_047434826.1 | c.*1251C>T | 3_prime_UTR_variant | 11/11 | XP_047290782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBFA2T3 | ENST00000268679.9 | c.1912C>T | p.Arg638Cys | missense_variant | 12/12 | 1 | NM_005187.6 | ENSP00000268679.4 | ||
CBFA2T3 | ENST00000327483.9 | c.1654C>T | p.Arg552Cys | missense_variant | 11/11 | 1 | ENSP00000332122.5 | |||
CBFA2T3 | ENST00000563856.1 | n.879C>T | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
CBFA2T3 | ENST00000563920.1 | n.1017C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000988 AC: 1AN: 101202Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 55946
GnomAD3 exomes
AF:
AC:
1
AN:
101202
Hom.:
AF XY:
AC XY:
0
AN XY:
55946
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000747 AC: 10AN: 1338682Hom.: 0 Cov.: 31 AF XY: 0.00000305 AC XY: 2AN XY: 656138
GnomAD4 exome
AF:
AC:
10
AN:
1338682
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
656138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.1912C>T (p.R638C) alteration is located in exon 12 (coding exon 12) of the CBFA2T3 gene. This alteration results from a C to T substitution at nucleotide position 1912, causing the arginine (R) at amino acid position 638 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
B;B
Vest4
MVP
MPC
0.97
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at